Published

Investigational drugs for assisting psychotherapy for posttraumatic stress disorder (PTSD): emerging approaches and shifting paradigms in the era of psychedelic medicine.

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal: Expert opinion on investigational drugs
Date: 2022-02-01
Source: PubMed
DOI: 10.1080/13543784.2022.2035358
PubMed: 35188023

Authors

Averill LA Abdallah CG

Watch author

Derived topics and classifications

psilocybin PTSD Neuroplasticity Other

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Retreat from racism: A psychedelic group experience for racial stress and traumaPsychedelics · 2026-07-30 Defining 'psychedelic'.Journal of psychopharmacology (Oxford, England) · 2026-08-17 PsiloStudy: A Phase 2 Single-site, Double-blind, Placebo-controlled, Randomized Clinical Trial With an Open-label Extension Phase to Examine the Safety, Subjective Experiences, Acute Effects, and Suitability of Psilocybin Combined With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD)ClinicalTrials.gov · 2026-08-13 Psychedelic Therapy for DepressionUnknown journal · 2026-08-11 Therapeutic potential of classic and non-classic psychedelics in neurodevelopmental disorders: Opportunities and challenges.Pharmacological research · 2026-08-06 Classic Psychedelics for Chronic Pain: A Critical Review of the Literature and Practical Advice for Clinicians.Drugs · 2026-08-01 A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy study.The International journal on drug policy · 2026-08-01 Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery modelPsychedelics · 2026-12-01